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Protein carbamylation links 
uremia, inflammation, and 
atherogenesis
It has long been known that the urea-generated molecule 
cyanate can modify lysine residues and generate homocitrul-
line (also known as ε-carbamyllysine) in a process called 
carbamylation. This carbamylation of amino acids, proteins, 
and other molecules changes their structure and function, 
thus modifying the activity of enzymes, cofactors, hormones, 
low-density lipoproteins, antibodies, receptors, and transport 
proteins. Antibodies speciﬁc for homocitrulline locate car-
bamylated proteins in neutrophils, monocytes, and erythro-
cytes. Cyanate spontaneously transformed from urea increases 
as renal function decreases; carbamylated proteins have been 
found in renal tissue from uremic patients but not in normal 
transplanted kidneys. Carbamylated proteins isolated from 
uremic subjects have been shown to have decreased biological 
activity, and it has been hypothesized that they posses pro-
atherosclerotic activities, perhaps contributing to the severe 
atherosclerosis of patients with renal failure. Because of the 
extremely low levels of protein carbamylation when normal 
plasma levels of urea are present, the potential involvement 
of this pathway in atherosclerotic vascular disease in the 
absence of renal failure has not until now been explored. In 
a recent article, Wang et al. report a biochemical pathway 
involving the enzyme myeloperoxidase (MPO) that causes 
protein carbamylation. MPO is a heme protein abundant in 
neutrophils, monocytes, and certain tissue macrophages, such 
as those found in human atheroma. The authors found that 
MPO promotes protein carbamylation during inﬂammation 
and within human atherosclerotic plaque (Figure). Further, 
like low-density lipoprotein isolated from uremic patients, 
MPO-carbamylated lipoproteins had atherogenic properties. 
Wang et al. also found that blood levels of protein-bound 
homocitrulline correlated with increased cardiovascular risk 
in patients. This study newly identiﬁes a biochemical pathway 
that is likely to be important in the promotion of atherogen-
esis and that may clarify the mechanisms responsible for the 
severity of this disease in patients with end-stage renal failure. 
(Nat Med 2007; 13: 1176–1184)
Juan Oliver
Vasopressin V2 receptor expression 
along the nephron
In the kidney, two receptors for arginine vasopressin (AVP), V1a 
and V2 receptors (V1aR and V2R), have been characterized. V1aR 
is localized in the renal vasculature and glomeruli and mediates 
the vasopressor eﬀect of AVP. The tubular antidiuretic eﬀect of 
AVP is mediated by the V2R and adenylyl cyclase-dependent 
cAMP signaling. The collecting duct is the principal target for 
the antidiuretic action of AVP, but data indicate that AVP has 
functions in the distal tubule and the thick ascending limb (TAL). 
Despite the prominent functional role of V2R-mediated eﬀects of 
AVP in the kidney, the exact location of this receptor in diﬀerent 
nephron segments and cell types remains somewhat unclear. In a 
new study, Mutig et al. present a detailed description of the distri-
bution of V2R mRNA and protein in the diﬀerent nephron seg-
ments in mice, rat and human kidneys. The diﬀerent cell types of 
the renal tubules were identiﬁed by speciﬁc markers. They found 
solid expression of V2R mRNA in the medullary TAL (MTAL), 
macula densa, connecting tubule, and cortical and medullary col-
lecting duct, and weaker expression in the cortical TAL and distal 
convoluted tubule, in all three species (Figure). Previous stud-
ies have shown that in the TAL, AVP stimulates transepithelial 
NaCl transport by increasing abundance and phosphorylation of 
Na+-K+-2Cl– cotransporter type 2 (NKCC2). The authors found 
that macula densa cells not only had high levels of V2R mRNA 
but also constitutively showed strong NKCC2 phosphorylation. 
Human carotid atherosclerotic plaque immunostained with antibodies 
against MPO (left) or carbamyl proteins (middle). The merged image (right) 
reveals colocalization of MPO and carbamyl proteins. Nuclei were stained 
with DAPI.
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Zonal and segmental distribution of baseline vasopressin V2 receptor 
(V2R) mRNA expression in rat, mouse, and human renal epithelia. Kidney 
zones are cortex (C), outer medulla (OM) with outer stripe (OS) and inner 
stripe (IS), and inner medulla (IM). Tubule segments are medullary and 
cortical thick ascending limb (MTAL and CTAL), macula densa (MD), distal 
convoluted tubule (DCT), connecting tubule (CNT), and cortical and 
medullary collecting duct (CCD and MCD).
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These results suggest that in all three species comparably signiﬁ-
cant eﬀects of vasopressin-induced V2R signaling in MTAL and 
in connecting tubule/collecting duct principal cells occur. Strong 
V2R expression in the macula densa is an intriguing ﬁnding that 
may improve understanding of tubuloglomerular feedback. (Am 
J Physiol Renal Physiol 2007; 293: F1166–F1177)
Juan Oliver
Claudin-16 and magnesium renal 
handling
The human renal disorder familial hypomagnesemia with 
hypercalciuria and nephrocalcinosis (FHHNC) is character-
ized by renal Mg2+ and Ca2+ wasting, progressive impairment 
of renal function, nephrocalcinosis, and chronic renal failure. 
FHHNC is genetically linked to mutations in the gene of claudin-
16 (CLDN16), which is expressed exclusively in the kidney. The 
claudins comprise a large gene family encoding structural com-
ponents of the tight junction, the principal regulators of paracel-
lular permeability that, needless to say, have tight junctions that 
play important roles in regulating ion reabsorption in the kidney. 
But the molecular mechanisms underlying the renal dysfunction 
in FHHNC remain unknown. Using lentiviral transgenic RNA 
interference, Hou et al. now report generation of CLDN16-deﬁ-
cient transgenic mouse lines and describe the physiological func-
tion of CLDN16. In the TAL of the nephron, electrogenic NaCl 
reabsorption generates a lumen-positive transepithelial potential, 
which drives the reabsorption of Mg2+ and Ca2+. It is a diﬀusion 
potential between luminal and basolateral extracellular spaces if 
they are separated by cation-selective tight junctions. The authors 
show that the loss of CLDN16 (Figure) caused tight junctions in 
the TAL to lose the cation selectivity, leading to dissipation of 
the lumen-positive potential with concomitant loss of the driv-
ing force for Mg2+ reabsorption. Claudin-16 knock-down mice 
exhibited chronic renal wasting of magnesium and calcium and 
developed renal nephrocalcinosis. Thus, claudin-16 plays a key 
role in maintaining the paracellular cation selectivity of the 
TALs of the nephron by forming a nonselective paracellular 
cation channel, rather than a previously proposed selective 
Mg2+/Ca2+ channel. This model clariﬁes the pathogenesis of 
FHHNC and suggests that analysis of tight junction proteins 
may illuminate renal electrolyte handling and disorders. (J Biol 
Chem 2007; 282: 17114–17122)
Qais Al-Awqati
Hypertension in mice with deletion 
of calcitonin gene-related peptide 
receptor
Calcitonin gene-related peptide (CGRP) is a 37-amino acid 
neuropeptide produced in the neural body of dorsal root gan-
glion cells and released from sensory nerve endings. There 
are two isoforms of CGRP, α and β. Whereas αCGRP is pro-
duced mainly in the nervous system, βCGRP is produced in 
neuronal tissues but also in enteric nerves and in immune 
cells. Pharmacologically, αCGRP possesses very potent 
vasodilatory activity. Most blood vessels are surrounded by 
a dense perivascular neural network, suggesting an impor-
tant role for CGRP in vascular regulation. It has long been 
suspected that αCGRP and βCGRP are involved in arterial 
pressure control, but their precise functional role and devel-
opment remain unclear. In addition, development of several 
αCGRP-deﬁcient mice has provided conﬂicting results. The 
CGRP receptor consists of a seven-transmembrane G protein-
coupled receptor called the calcitonin receptor-like receptor 
(CLR) and a single membrane-spanning protein called recep-
tor activity-modifying protein-1 (RAMP1), which determines 
the speciﬁcity of the CGRP receptor. To clarify the physiologi-
cal functions of CGRP mediated through the CLR/RAMP1 
receptors in vivo, Tsujikawa et al. generated RAMP1-deﬁcient 
mice. They found that RAMP1–/– mice exhibited severe hyper-
tension, which resulted mainly from a vasodilatory disorder 
caused by deﬁcient αCGRP signal transduction. In addition, 
RAMP1–/– mice exhibited a signiﬁcant increase in serum 
CGRP and proinﬂammatory cytokine levels after lipopoly-
saccharide administration. These results indicate that CGRPs 
transduce physiologically critical signals in the regulation of 
blood pressure, and that CLR/RAMP1 receptors are involved 
in the inﬂammatory response. (Proc Natl Acad Sci USA 2007; 
104: 16702–16707)
Juan Oliver
CLDN16 in the kidney. Sections from wild-type mouse kidneys (a and b) 
show CLDN16 localization in the tight junctions of tubules in medullary 
rays (that is, the TAL). In CLDN16 knock-down mouse kidneys (c and d), 
CLDN16 staining disappears.
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